InvestorsHub Logo
icon url

space1230

04/22/17 8:51 PM

#117976 RE: Drugdoctor #117975

Thanks man. Same to u. BETS is in that nice transition period that a company thrives for. I am sure that a valuable lesson was learned (to them) about toxic financing. Many have to learn the hard way. 200k becomes 800k very quickly with these notes. This Apollo got out of control. But now BETS has crossed the finish line and needs to deplete all of these tranches and rid Apollo because this company is very real and the revenue is very very real and quite impressive!!